Clarity Pharmaceuticals Ltd.ASX: CU6

Theranostic prostate cancer trial advances to cohort 2

May 24, 2023 at 4:12 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment